ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2703

Single Cell Analysis of TCRs from CD8+ T Cells in Sjogren’s Syndrome

Michelle L. Joachims1, Christina Lawrence1, Richard C. Pelikan1, Kerry M. Leehan1, Lida Radfar2, David M. Lewis3, Astrid Rasmussen1, R. Hal Scofield1, Kiely Grundahl1, Kathy L. Sivils1, Linda F. Thompson1 and A. Darise Farris1, 1Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Department of Oral Diagnosis and Radiology, University of Oklahoma College of Dentistry, Oklahoma City, OK, 3Department of Oral Pathology, University of Oklahoma College of Dentistry, Oklahoma City, OK

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: salivary gland and viruses, Sjogren's syndrome, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: T Cell Biology and Targets in Autoimmune Disease Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Sjögren’s syndrome (SS) is an autoimmune exocrinopathy characterized by focal lymphocytic infiltration of the salivary and lacrimal glands, severe dry eyes and mouth, fatigue and musculoskeletal pain. How the T cell-dominated salivary gland (SG) inflammation is connected to pathologic and clinical features of SS is poorly understood. We reported that SG CD4+ T cell clonal expansion is antigen-driven and correlated with reduced salivary flow and increased SG fibrosis. To determine whether the extent of SG CD8+ T cell clonal expansion is related to pathologic features of disease, we evaluated the CD8+ TCR repertoire of the same subjects.

Methods: Multiplex single cell RT-PCR was used to retrieve paired TCR α and β sequences from SG and peripheral blood (PB) memory CD8+ T cells from 11 subjects meeting the 2016 ACR/EULAR classification criteria for primary Sjögren’s syndrome. The extent of SG and PB CD8+ T cell clonal expansion was compared between SG and PB and evaluated for relationships with pathologic and clinical disease features using Mann-Whitney and Spearman rank correlation tests.

Results: Our cohort repertoire consisted of over 2,800 TCR sequences isolated from a median of 28 (range 4-67) SG and 19 (range 4-52) PB cells evaluated per subject. Clonal expansions of SG and PB CD8+ T cells were detected in all subjects. Expansions were extensive in both tissue compartments, ranging from 8.3-66.3% in SG (mean 34.9) and 5-48.5% in PB (mean 23.1). Although the percentage of clonally expanded CD8+ T cells did not differ significantly between SG and PB, there were significantly higher levels of clonally expanded SG CD8+ T cells compared to SG CD4+ T cells from the same individuals. Further, many subjects exhibited large expansions, with 60% of individuals having at least one clonal expansion of 4 or more cells. In contrast to our prior observations in CD4+ T cells, the degree of SG CD8+ T cell clonal expansion did not significantly correlate with measures of oral disease. However, identical clonal expansions were detected in SG and PB in 5/11 patients (45%), indicating significant trafficking of CD8+ T cells in both tissues. Further, several clonotypes of expanded cells shared between SG and PB were identified as viral-specific, indicating the presence of activated viral-specific T cells in the SG of SS patients.

Conclusion: Although relatively small numbers of T cells were evaluated in this study, clonally expanded CD8+ T cells were abundant in both the SG and PB of SS patients but did not obviously correlate with measures of disease. Known viral-specific T cells were found in SG and PB from SS patients, adding evidence for viral-initiated or -driven CD8+ T cell proliferation in SS.


Disclosure: M. L. Joachims, None; C. Lawrence, None; R. C. Pelikan, None; K. M. Leehan, None; L. Radfar, None; D. M. Lewis, None; A. Rasmussen, None; R. H. Scofield, None; K. Grundahl, None; K. L. Sivils, None; L. F. Thompson, None; A. D. Farris, None.

To cite this abstract in AMA style:

Joachims ML, Lawrence C, Pelikan RC, Leehan KM, Radfar L, Lewis DM, Rasmussen A, Scofield RH, Grundahl K, Sivils KL, Thompson LF, Farris AD. Single Cell Analysis of TCRs from CD8+ T Cells in Sjogren’s Syndrome [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/single-cell-analysis-of-tcrs-from-cd8-t-cells-in-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-analysis-of-tcrs-from-cd8-t-cells-in-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology